2023-06-01
LKtime Biotech Enters Strategic Cooperation with Shanghai Bio-Pharmaceutical Technology Development Center and Adds a 2000L Production Line
2024-08-17
LKtime Biotech Empowers || Celebrating Client Organization's "Recombinant Zoster Vaccine (CHO Cell)" IND Approval
2024-08-16
LKtime Biotech and Boxiao Biopharmaceutical Forge Strategic Partnership to Pioneer New Chapter in Biologics Field
2024-07-02
LKtime raises 190 million yuan in Series B funding, setting a new benchmark for biologics CDMO in China
2024-08-17
LKtime Biotech Empowers || Celebrating Client Organization's "Recombinant Zoster Vaccine (CHO Cell)" IND Approval
Learn More
2024-08-16
LKtime Biotech and Boxiao Biopharmaceutical Forge Strategic Partnership to Pioneer New Chapter in Biologics Field
Learn More
2024-07-02
LKtime raises 190 million yuan in Series B funding, setting a new benchmark for biologics CDMO in China
Learn More
2024-02-27
Good News | LKtime Biotech Successfully Selected as a National High-Tech Enterprise
Learn More
2024-02-05
New Certification Achieved! LKtime Biotech Successfully Passes Pathogenic Microorganism Laboratory Registration
Learn More
2023-09-14
Lktime Biotech Obtains Pathogenic Microorganism Laboratory Registration Certificate (BSL-2)
Learn More
2023-06-01
LKtime Biotech Enters Strategic Cooperation with Shanghai Bio-Pharmaceutical Technology Development Center and Adds a 2000L Production Line
Learn More
2023-03-21
Strategic Cooperation | Shanghai LKtime Biotech and Dartsbio (Guangdong) Officially Sign Strategic Cooperation Agreement
Learn More